ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Cannabist Company Holdings Inc

Cannabist Company Holdings Inc (CBST)

0,145
-0,01
(-6,45%)
Geschlossen 05 Dezember 10:00PM
Echtzeitdaten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
0,145
Gebot
0,14
Fragen
0,15
Volumen
149.383
0,14 Tagesbereich 0,15
0,135 52-Wochen-Bereich 0,83
Handelsende
0,155
Handelsbeginn
0,145
Letzte Trade
1500
@
0.145
Letzter Handelszeitpunkt
Durchschnittliches Volumen (3 Mio.)
501.098
Finanzvolumen
-
VWAP
-

CBST Neueste Nachrichten

Verano Announces Closing of Acquisition of Arizona and Virginia Subsidiaries of The Cannabist Company, Becomes Exclusive Cannabis Operator for HSA 5 in Eastern Virginia and Strengthens Arizona Footprint

Acquisitions Expand Verano’s Footprint to 14 States, 15 Cultivation and Production Facilities, and 150 Dispensaries Nationwide CHICAGO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Verano Holdings Corp...

Dana Holding Set to Join the S&P MidCap 400

Dana Holding Set to Join the S&P MidCap 400 PR Newswire NEW YORK, Jan. 20, 2015 NEW YORK, Jan. 20, 2015 /PRNewswire/ -- Dana Holding Corp. (NYSE: DAN) will replace Cubist Pharmaceuticals Inc...

Cubist Announces Withdrawal of Listing of CVRs (CBSTZ) from NASDAQ Global Select Market

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it will voluntarily withdraw the contingent value rights (CVRs) it issued under a Contingent Value Rights Agreement dated...

Cubist meldet FDA-Zulassung seines neuen Antibiotikums ZERBAXA™ (Ceftolozan/Tazobactam) für komplizierte Harnwegsinfektion...

ZERBAXA geht bestimmte gefährliche und resistente gramnegative Bakterien anErstes in den USA unter dem GAIN-Gesetz zugelassenes Antibiotikum gegen gramnegative Bakterien Cubist...

Cubist annonce l’approbation par la FDA du nouvel antibiotique ZERBAXA™ (ceftolozane/tazobactam) pour le traitement des i...

ZERBAXA s’attaque à certaines bactéries à Gram négatif graves et résistantes Premier nouvel antibiotique approuvé aux États-Unis dans le cadre de la GAIN Act pour le traitement des...

Cubist Announces FDA Approval of New Antibiotic ZERBAXA™ (Ceftolozane/Tazobactam) for Complicated Urinary Tract & Complicat...

ZERBAXA addresses certain serious and resistant Gram-negative bacteriaFirst new antibiotic approved in U.S. under the GAIN Act that treats Gram-negative bacteria Cubist...

Merck Begins Tender Offer to Acquire Cubist

Merck (NYSE:MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender to purchase all outstanding shares of common stock of Cubist...

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Cubist Pharmaceuticals, Inc. R...

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Cubist Pharmaceuticals, Inc. Regarding the Fairness of the Sale of the Company PR Newswire BALA...

CUBIST PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Cubist Pharmaceuticals, Inc. Over ...

CUBIST PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Cubist Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Merck & Co. Inc...

SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Cubist Pharmaceuticals, Inc. And Encourag...

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.015-9.3750.160.1650.143557080.15411824CS
4-0.055-27.50.20.2350.1359709540.1638163CS
12-0.16-52.45901639340.3050.3550.1355010980.21532033CS
26-0.16-52.45901639340.3050.420.1355138840.26679909CS
52-0.325-69.14893617020.470.830.1359949590.45971218CS
156-1.535-91.3690476191.681.760.13510835550.56269744CS
260-1.535-91.3690476191.681.760.13510835550.56269744CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
CDMNCanadian Manganese Company Inc
$ 0,075
(50,00%)
441,5k
IFSSInterfield Global Software Inc
$ 0,07
(27,27%)
1.000
DEFIValour Inc
$ 4,86
(18,25%)
2,99M
BMNDBiomind Labs Inc
$ 0,455
(16,67%)
114,76k
BTQBTQ Technologies Corp
$ 0,315
(8,62%)
212,9k
IBERIberAmerican Lithium Corp
$ 0,045
(-25,00%)
81,78k
HOLDImmutable Holdings Inc
$ 0,135
(-12,90%)
17,8k
LABZMetaspere Labs Inc
$ 0,125
(-7,41%)
9,5k
CBSTCannabist Company Holdings Inc
$ 0,145
(-6,45%)
149,38k
NETZCarbon Streaming Corporation WTS B
$ 0,485
(-3,00%)
831
DEFIValour Inc
$ 4,86
(18,25%)
2,99M
TILTTILT Holdings Inc
$ 0,005
(0,00%)
466k
CDMNCanadian Manganese Company Inc
$ 0,075
(50,00%)
441,5k
VERSVerses AI Inc
$ 0,41
(3,80%)
432,27k
FCGS.UFidelity Global Small Cap Opportunities Fund
US$ 10,83
(0,37%)
412,46k
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock